Results 11 to 20 of about 417,692 (230)

Elevated serum Interleukin-39 in Myasthenia gravis: a possible biomarker

open access: yesEuropean Journal of Medical Research
Background Interleukin-39 (IL-39) is a cytokine implicated in immune regulation and autoimmune diseases, but its role in myasthenia gravis (MG) is unknown. This study aimed to investigate serum IL-39 levels in MG patients. Methods Serum IL-39 levels were
Kun Jia   +4 more
doaj   +3 more sources

Association between salivary and serum Interleukin-39 and osteopontin in periodontitis patients: case-control study

open access: yesJournal of Baghdad College of Dentistry
Background: Cytokines have a crucial role in developing chronic inflammation and the inflammatory response. Some interleukins, such as interleukin-39 (IL-39), have unknown specific roles in the pathogenesis of periodontitis.
Sarah J Al Lami   +2 more
doaj   +2 more sources

Interleukin 39: a new member of interleukin 12 family. [PDF]

open access: yesCent Eur J Immunol, 2020
Interleukin (IL)-12 family member is a heterodimer glycoprotein, composed of two covalently linked subunits, a and b chains. The a subunit consists of IL-23p19, IL-27p28, and IL-12p35, and the b subunit includes IL-12p40 and Epstein-Barr virus-induced gene (Ebi3).
Lu Z, Xu K, Wang X, Li Y, Li M.
europepmc   +3 more sources

Interleukin-37 and interleukin-39 as novel immunometabolic biomarkers in metabolic syndrome: A cross-sectional study. [PDF]

open access: yesMedicine (Baltimore)
Metabolic syndrome (MetS) is characterized by abdominal obesity, dyslipidemia, hypertension, and insulin resistance, all driven by chronic low-grade inflammation. This study aimed to evaluate serum interleukin-37 (IL-37) and interleukin-39 (IL-39) levels as potential immunometabolic biomarkers in MetS.
Keskin L   +3 more
europepmc   +3 more sources

A Role of Serum Interleukin-39 and Association with Small and Non-Small Cell Carcinoma in Lung Cancer Patients. [PDF]

open access: yesAsian Pac J Cancer Prev
Lung cancer is the second most common malignancy globally and the leading cause of cancer-related deaths. Interleukin-39 (IL-39), a member of the IL-12 family secreted by B cells, acts as a pro-inflammatory cytokine and induces IL-23p19 expression in endothelial cells. Recent findings suggest reduced IL-39 expression in autoimmune thyroid disorders and
Addai Ali H   +8 more
europepmc   +4 more sources

Interleukin-39 aggravates sepsis by inducing self-sustaining neutrophil activation in the lungs via the CXCL1-CXCR2 pathway. [PDF]

open access: yesInt J Biol Sci
Zhang J   +15 more
europepmc   +2 more sources

Interleukin -39 Expression in Pleural Effusion and Its Diagnostic Value for Tuberculous Pleurisy. [PDF]

open access: yesJ Inflamm Res
This study aimed to assess Interleukin-39 (IL-39) levels in various types of pleural effusion (PE), explore IL-39's diagnostic value in tuberculous pleurisy, analyze its correlation with other PE and tuberculosis indicators, and confirm the involvement of IL-39 in tuberculosis infection and the resulting inflammatory response.This study enrolled 113 ...
Song X   +11 more
europepmc   +5 more sources

An assessment of serum interleukin - 39 in rheumatoid arthritis patients from Iraq

open access: yesBiomedicine, 2022
Introduction and Aim: The pro-inflammatory cytokine IL-39, a member of the IL-12 family plays a key role in the inflammatory response by modulating immune cell activity and inflammation. A literature search shows no study undertaken for the effect of IL-39's on arthritis so far.
null Wafaa Tialp Mohammed   +2 more
openaire   +1 more source

Interleukin-23 receptor signaling by interleukin-39 potentiates T cell pathogenicity in acute graft-versus-host disease

open access: yesAmerican Journal of Transplantation, 2021
IL-12 (p35/p40) and IL-23 (p19/p40) signal through IL-12R (IL-12Rβ2/β1) and IL-23R (IL-23Rα/IL-12Rβ1), respectively, which can promote pathogenic T lymphocyte activation, differentiation, and function in graft-versus-host disease (GVHD). With the use of murine models of allogeneic hematopoietic cell transplantation (HCT), we found that IL-12Rβ1 on ...
David Bastian   +10 more
openaire   +2 more sources

Helicobacter pylori eradication: influence of interleukin-1beta –31 C/T polymorphism

open access: yesBrazilian Journal of Infectious Diseases, 2018
Aim: To analyze the influence of the –31 C/T polymorphism of the interleukin-1β gene on Helicobacter pylori eradication therapy success in patients with functional dyspepsia. Methods: Functional dyspepsia was diagnosed according to the Rome III criteria.
Tássia Flores Rech   +9 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy